Clinical Trials Directory

Trials / Completed

CompletedNCT01686048

The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

Status
Completed
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Ambrosia is known for its allergenicity in the USA causing hay fever and asthma. Israel has always been considered "clean" of Ambrosia but over the past years growth of Ambrosia plants has been detected in several locations in Israel. In the proposed study, patients referred for routine allergic evaluation will also be skin tested with Ambrosia allergens, in addition to their regular prick skin tests with all other airborne allergens.

Conditions

Timeline

Start date
2015-04-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2012-09-17
Last updated
2015-10-07

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01686048. Inclusion in this directory is not an endorsement.